BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 2018; 24(15): 1641-1649 [PMID: 29686471 DOI: 10.3748/wjg.v24.i15.1641]
URL: https://www.wjgnet.com/1007-9327/full/v24/i15/1641.htm
Number Citing Articles
1
Brian I. Carr, Vito Guerra, Rossella Donghia, Seai Yilmaz. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular CarcinomaJournal of Gastrointestinal Cancer 2021;  doi: 10.1007/s12029-021-00720-z
2
Javeria Khalid, Mohammad Umar, Tofeeq Ur-Rehman, Mashhood Ali, Gul Majid Khan. Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapyInfectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00300-z
3
Ahmed A. Ghafar, Elsayed Ghoneem, Salah Rozaik, Ahmed Akef, Metwaly Mortada. Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolizationThe Egyptian Journal of Internal Medicine 2019; 31(3): 254 doi: 10.4103/ejim.ejim_110_18
4
Ahmed Saleh, Ahmed M. Saed, Mostafa Mansour. Association of IL-10 and TNF-α polymorphisms with risk and aggressiveness of hepatocellular carcinoma in patients with HCV-related cirrhosisEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00052-w
5
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
6
Ping Sun, Shihai Chen, Yanlong Li. The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinomaMedicine 2020; 99(11): e19438 doi: 10.1097/MD.0000000000019438